Sara Santorelli

ORCID: 0000-0001-5344-1676 · 5 papers in corpus
article 2021
In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosis
Pharmacology research & perspectives ·doi:10.1002/prp2.759

Endometriosis is a chronic disease, characterized by the growth of endometrial-like cells outside the uterine cavity. Due to its complex pathophysiology, a totally resolving cure is yet to be found. The aim of this study was to compare the …

article 2018
High dose etonogestrel is comparable to ovariectomy in a murine endometriosis model
article 2017
An in vivo mouse model for endometriosis to validate the efficacy of new drugs
article 2017
Fibroblast growth factor receptor (FGFR) inhibition: a new target for endometriosis therapy
article 2016
Preliminary assessment of potential local therapies for endometriosis.

Preliminary assessment of potential local therapies for endometriosis.